
|Articles|March 1, 2004
Psoriasis therapies targeted
Washington - Findings of a retrospective analysis designed to characterize comorbidities in the psoriasis population and adverse events associated with systemic therapies will hopefully increase physician understanding of their psoriasis patients and thereby enhance patient care, said Daniel J. Pearce, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD
3
Exploring Type 2 Inflammation and Psoriasis Management at Horizons in Advanced Practice
4
Clinicians See Intersection of Weight Loss and Facial Aging
5


















